X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (67947) 67947
Book Review (12265) 12265
Newsletter (6848) 6848
Publication (2589) 2589
Magazine Article (645) 645
Newspaper Article (630) 630
Conference Proceeding (373) 373
Book Chapter (185) 185
Trade Publication Article (84) 84
Book / eBook (74) 74
Dissertation (44) 44
Transcript (40) 40
Reference (19) 19
Web Resource (18) 18
Paper (8) 8
Data Set (2) 2
Presentation (2) 2
Archival Material (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56230) 56230
humans (49981) 49981
antihypertensive agents - therapeutic use (35357) 35357
male (31618) 31618
hypertension - drug therapy (30638) 30638
female (26301) 26301
hypertension (24389) 24389
middle aged (20710) 20710
aged (16781) 16781
blood pressure - drug effects (15726) 15726
antihypertensive drugs (15594) 15594
adult (14295) 14295
animals (13408) 13408
antihypertensive agents - pharmacology (12825) 12825
hypertension - physiopathology (10805) 10805
blood pressure (10704) 10704
antihypertensive agents - administration & dosage (9577) 9577
peripheral vascular disease (8936) 8936
risk factors (8554) 8554
rats (8493) 8493
pharmacology & pharmacy (8421) 8421
antihypertensive agents - adverse effects (7823) 7823
treatment outcome (7769) 7769
hypertension - complications (6753) 6753
blood-pressure (6659) 6659
abridged index medicus (6553) 6553
research (6008) 6008
drug therapy (5987) 5987
drug therapy, combination (5898) 5898
cardiac & cardiovascular systems (5363) 5363
medicine, general & internal (5177) 5177
angiotensin-converting enzyme inhibitors - therapeutic use (4412) 4412
time factors (4382) 4382
aged, 80 and over (4364) 4364
care and treatment (3886) 3886
mortality (3748) 3748
antihypertensive agents (3714) 3714
double-blind method (3559) 3559
hypertension - diagnosis (3469) 3469
dose-response relationship, drug (3465) 3465
prospective studies (3283) 3283
hypertension - epidemiology (3260) 3260
heart rate - drug effects (3249) 3249
risk (3207) 3207
analysis (3202) 3202
prevalence (3069) 3069
follow-up studies (3032) 3032
blood pressure - physiology (2996) 2996
calcium channel blockers - therapeutic use (2982) 2982
reports (2842) 2842
medical research (2809) 2809
health aspects (2800) 2800
prevention (2713) 2713
therapy (2679) 2679
adrenergic beta-antagonists - therapeutic use (2642) 2642
diuretics (2634) 2634
medicine & public health (2624) 2624
clinical trials as topic (2617) 2617
management (2577) 2577
adolescent (2575) 2575
angiotensin (2559) 2559
drugs (2550) 2550
ophthalmology (2509) 2509
diabetes (2507) 2507
disease (2476) 2476
retrospective studies (2430) 2430
diuretics - therapeutic use (2421) 2421
rats, inbred shr (2392) 2392
medicine, experimental (2385) 2385
hypertension - etiology (2225) 2225
stroke (2211) 2211
randomized controlled trials as topic (2199) 2199
patient compliance (2074) 2074
hemodynamics - drug effects (2072) 2072
dosage and administration (2052) 2052
antihypertensive therapy (2037) 2037
urology & nephrology (2006) 2006
internal medicine (1999) 1999
angiotensin receptor antagonists (1955) 1955
cardiology (1942) 1942
prognosis (1940) 1940
hypertension - therapy (1908) 1908
cardiovascular diseases - prevention & control (1893) 1893
age factors (1871) 1871
antihypertensive treatment (1845) 1845
hypertension, pulmonary - drug therapy (1824) 1824
losartan (1809) 1809
rats, sprague-dawley (1808) 1808
intraocular pressure - drug effects (1790) 1790
cardiovascular disease (1785) 1785
tetrazoles - therapeutic use (1772) 1772
trial (1767) 1767
drug combinations (1745) 1745
pregnancy (1739) 1739
antihypertensives (1734) 1734
hypertension - blood (1733) 1733
renin-angiotensin system - drug effects (1714) 1714
angiotensin-converting enzyme inhibitors - pharmacology (1658) 1658
cardiovascular diseases (1654) 1654
clinical trials (1643) 1643
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Baycrest Hospital - Wellness Library (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (66961) 66961
German (2440) 2440
Russian (1536) 1536
French (1490) 1490
Japanese (816) 816
Spanish (606) 606
Chinese (436) 436
Polish (347) 347
Italian (317) 317
Portuguese (197) 197
Swedish (181) 181
Czech (154) 154
Danish (146) 146
Norwegian (133) 133
Hungarian (130) 130
Dutch (125) 125
Romanian (65) 65
Croatian (57) 57
Ukrainian (57) 57
Finnish (48) 48
Hebrew (46) 46
Bulgarian (45) 45
Serbian (33) 33
Slovak (31) 31
Turkish (29) 29
Korean (23) 23
Lithuanian (10) 10
Bosnian (4) 4
Slovenian (3) 3
Icelandic (2) 2
Persian (2) 2
Armenian (1) 1
Greek (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0161246 - e0161246
Journal Article
1984, Handbook of hypertension, ISBN 9780444903419, Volume 3, xi, 373
Book
1992, Progress in hypertension, ISBN 9067641405, Volume 2, x, 375
Book
Advances in Therapy, ISSN 0741-238X, 5/2015, Volume 32, Issue 5, pp. 404 - 417
Journal Article
Circulation, ISSN 0009-7322, 03/2006, Volume 113, Issue 9, pp. 1213 - 1225
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 04/2010, Volume 10, Issue 2, pp. 95 - 103
Background The Polycap™ (polypill; aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol, and hydrochlorothiazide) was found to be safe and effective... 
Drug-interactions | Ramipril, pharmacokinetics | Aspirin, pharmacokinetics | Hydrochlorothiazide, pharmacokinetics | Salicylic-acid, pharmacokinetics | Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin, pharmacokinetics | Atenolol, pharmacokinetics | Risk-factors | Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin, drug interactions | Simvastatin, pharmacokinetics | Cardiovascular-disorders, treatment | Pharmacotherapy | Medicine & Public Health | Cardiology | Pharmacology/Toxicology | CYTOCHROME-P450 | CARDIAC & CARDIOVASCULAR SYSTEMS | LOW-DOSE ASPIRIN | PHARMACOKINETICS | METABOLISM | FORMULATIONS | SIMVASTATIN ACID | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | BIOEQUIVALENCE | Hydrochlorothiazide - pharmacokinetics | Simvastatin - adverse effects | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Aspirin - pharmacokinetics | Biological Availability | Male | Aspirin - administration & dosage | Ramipril - administration & dosage | Young Adult | Capsules | Drug Interactions | Aspirin - adverse effects | Atenolol - pharmacokinetics | Platelet Aggregation Inhibitors - administration & dosage | Adult | Platelet Aggregation Inhibitors - pharmacokinetics | Atenolol - administration & dosage | Ramipril - adverse effects | Tandem Mass Spectrometry - methods | Platelet Aggregation Inhibitors - adverse effects | Hydrochlorothiazide - adverse effects | Cardiovascular Diseases - etiology | Hypolipidemic Agents - adverse effects | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Ramipril - pharmacokinetics | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Simvastatin - pharmacokinetics | Antihypertensive Agents - adverse effects | Cross-Over Studies | Adolescent | Hypolipidemic Agents - administration & dosage | Atenolol - adverse effects | Chromatography, Liquid - methods | Hypolipidemic Agents - pharmacokinetics | Drug Combinations | Prevention | Complications and side effects | Drug interactions | Dosage and administration | Research | Cardiovascular diseases | Risk factors | Cardiovascular agents | Index Medicus
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 04/2003, Volume 289, Issue 13, pp. 1652 - 1658
Journal Article